KR20080007985A - A method for purifying 5'-inosinic acid fermentation broth via crystallization process - Google Patents

A method for purifying 5'-inosinic acid fermentation broth via crystallization process Download PDF

Info

Publication number
KR20080007985A
KR20080007985A KR1020060067305A KR20060067305A KR20080007985A KR 20080007985 A KR20080007985 A KR 20080007985A KR 1020060067305 A KR1020060067305 A KR 1020060067305A KR 20060067305 A KR20060067305 A KR 20060067305A KR 20080007985 A KR20080007985 A KR 20080007985A
Authority
KR
South Korea
Prior art keywords
activated carbon
fermentation broth
organic solvent
purifying
disodium
Prior art date
Application number
KR1020060067305A
Other languages
Korean (ko)
Other versions
KR100828706B1 (en
Inventor
이윤재
박남섭
한승우
이은석
윤태상
유재헌
홍순원
김유신
Original Assignee
씨제이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨제이 주식회사 filed Critical 씨제이 주식회사
Priority to KR1020060067305A priority Critical patent/KR100828706B1/en
Priority to CNA2007101294873A priority patent/CN101109017A/en
Publication of KR20080007985A publication Critical patent/KR20080007985A/en
Application granted granted Critical
Publication of KR100828706B1 publication Critical patent/KR100828706B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/32Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Abstract

A method for purifying disodium 5'-inosinate from a microorganism-fermented solution is provided to replace an ion exchange resin column process with a crystallization process by improving a conventional purification process, thereby capable of significantly decreasing the generating amount of the wastewater/waste solution and the amount of chemicals such as acid and alkali. A method for purifying disodium 5'-inosinate from a microorganism-fermented solution comprises the steps of: (a) culturing a 5'-inosinic acid producing microorganism and removing microorganisms therefrom through filtration, centrifugation or heat-treatment to prepare a fermented broth; (b) adding a hydrophilic organic solvent such as methanol, ethanol, propanol, isopropanol and a mixture thereof to the fermented broth to crystallize the disodium 5'-inosinate; (c) re-dissolving the crystals and decolorizing it using activated carbon; and (d) crystallizing the filtrate obtained by removing the activated carbon.

Description

결정화 공정을 이용한 5'-이노신산 발효액의 정제방법{A method for purifying 5'-Inosinic acid fermentation broth via crystallization process}Purification method of 5'-inosinic acid fermentation broth using crystallization process {A method for purifying 5'-Inosinic acid fermentation broth via crystallization process}

본 발명은 5'-이노신산 이나트륨(IMP2Na)의 정제방법에 관한 것이다. 보다 상세하게는 결정화 공정을 이용하여 5'-이노신산(IMP) 발효액으로부터 5'-이노신산 이나트륨염을 정제하는 방법에 관한 것이다. The present invention relates to a method for purifying disodium 5'-inosinate (IMP2Na). More specifically, the present invention relates to a method for purifying 5'-inosinate disodium salt from 5'-inosinic acid (IMP) fermentation broth using a crystallization process.

IMP와 같은 퓨린유도체 뉴클레오티드는 의약부문에서 대사장해의 예방치료제, 생장촉진제, 항암제 등의 원료로 사용되며 식품 분야에서는 조미료 등 식품첨가물로 사용되는 중요한 물질이다. 특히, IMP는 식품의 정미 성분으로서, 육류, 어류 등에 천연적으로 존재하는 물질이며, 어육추출법, RNA 효소 분해법, 미생물 발효법, 발효법과 합성법의 조합, RNA 화학분해와 합성의 조합 등을 통해 생산되고 있다. 그러나, 어떤 방법에 의하여 생산되어도, 그 결과물은 색소류, 당류, 아미노산류, 유기산류, 무기염류 등을 함유하고 있어 식품 첨가물로 사용될 수 있는 품질의 5'-이노신산 이나트륨을 얻기 위해서는 이들을 정제하여 불순물을 제거해야 한다.Purine derivative nucleotides such as IMP are used as raw materials for the prophylaxis, growth promoter, and anticancer agent of the large sea in the medical field, and are important substances used as food additives such as seasonings in the food field. In particular, IMP is a net ingredient of food, which is naturally present in meat, fish, etc., and is produced through fish extracting method, RNA enzymatic digestion method, microbial fermentation method, fermentation and synthesis method combination, RNA chemical decomposition and synthesis combination, etc. have. However, no matter which method is produced, the resultant contains pigments, sugars, amino acids, organic acids, inorganic salts, and the like, so that they can be purified to obtain disodium 5'-inosinate of quality that can be used as a food additive. Impurities must be removed.

지금까지 알려진 정제방법으로는 활성탄처리법, 이온교환막 처리법, 전기투 석법, 침전법, 강염기성 음이온 교환수지법, 강산성 양이온교환수지법, 강산성 양이온교환수지와 약염기성 음이온교환수지의 혼합법 등이 있다. Purification methods known to date include activated carbon treatment, ion exchange membrane treatment, electrodialysis, precipitation, strong basic anion exchange resin, strong acid cation exchange resin, strong acid cation exchange resin and weakly basic anion exchange resin, etc. .

미생물 발효완료액 내의 IMP를 정제하기 위한 종래의 일반적인 방법은 발효완료액 또는 막 여과공정을 거쳐 발효완료액 내의 균체가 제거된 여과액을 이온교환수지탑을 거쳐 이온성 불순물을 제거하고, 활성탄을 이용한 탈색공정 및 결정화 공정을 통해 최종 제품을 생산하는 것이다. 그러나, 이 방법은 폐수/폐액 발생량이 많고 관리 및 운전이 복잡하다는 단점을 갖는다. 산업적 규모에서의 활용을 위해 요구되는 경제성 및 생산성 측면에서 개선이 요구된다. A conventional method for purifying IMP in a microbial fermentation broth is through a fermentation broth or a membrane filtration process and a filtrate from which the cells in the fermentation broth are removed through an ion exchange resin tower to remove ionic impurities, and The final product is produced through the decolorization process and crystallization process. However, this method has the disadvantage of having a large amount of wastewater / waste solution and complicated management and operation. Improvements are needed in terms of economics and productivity required for industrial use.

따라서, 본 발명자들은 상기와 같은 단점을 해소하고자 이온교환수지탑 공정에 의한 IMP 정제공정을 개선하기 위한 실험을 거듭한 결과 공업적으로 관리가 용이하고, 폐수/폐액 발생이 적은 결정화 공정으로 발효 완료액 내의 IMP2Na 정제가 가능하다는 것을 발견하고 본 발명을 완성하기에 이르렀다. Therefore, the present inventors have repeatedly experimented to improve the IMP purification process by the ion exchange resin tower process in order to solve the above disadvantages, and the fermentation is completed with a crystallization process that is easy to manage industrially and generates less waste water / waste solution. It was found that IMP2Na purification in solution was possible and came to complete the present invention.

본 발명의 목적은 IMP 생산 미생물의 발효액에 포함된 IMP를 정제하기 위하여 종래에 사용되던 이온교환수지공정을 결정화 공정으로 대체하여 정제과정에서 발생되는 폐수/폐액 발생량 및 산, 염기와 같은 화학 약품 사용량을 대폭 감소시킬 수 있는 5'-이노신산 이나트륨을 정제하는 방법을 제공하는 것이다.An object of the present invention is to replace the conventional ion exchange resin process used to purify IMP contained in the fermentation broth of IMP producing microorganisms with a crystallization process, the amount of waste water / waste generated in the purification process and the amount of chemicals such as acid and base It is to provide a method for purifying disodium 5'-inosinate which can greatly reduce the amount of.

상기와 같은 목적을 달성하기 위해 본 발명은 미생물 발효액으로부터 5'-이노신산 이나트륨을 정제하는 방법을 제공하며, 상기 방법은:In order to achieve the above object, the present invention provides a method for purifying disodium 5'-inosinate from a microbial fermentation broth, the method comprising:

5'-이노신산 생산 균주를 배양하고, 균체를 제거하여 5'-이노신산을 포함하는 발효액을 얻는 단계; Culturing the 5'-inosinic acid producing strain, and removing the cells to obtain a fermentation broth containing 5'-inosinic acid;

상기 발효액에 친수성 유기용매를 첨가하여 5'-이노신산 이나트륨을 결정화하는 단계;Crystallizing disodium 5'-inosinate by adding a hydrophilic organic solvent to the fermentation broth;

상기 결정을 재용해하고 활성탄을 이용하여 탈색시키는 단계; 및Redissolution of the crystals and decolorizing with activated carbon; And

상기 활성탄을 제거하고 수득한 여과액을 결정화하는 단계;를 포함한다. And removing the activated carbon and crystallizing the filtrate obtained.

본 발명에 있어서, 발효에 사용되는 균주는 IMP를 생산하는 균주이면 어느 균주나 사용될 수 있다. 바람직하게는, IMP 발효에 빈번하게 사용되는 코리네박테리움 (Corynebacterium) 속 균주이다. 미생물의 발효 조건은 특별하게 제한되는 것은 아니며, 바람직하게는 다음과 같은 조성의 배지 및 발효 조건을 이용할 수 있다:In the present invention, any strain can be used as long as the strain used for fermentation is a strain producing IMP. Preferably, Corynebacterium (Corynebacterium) in strain that is used frequently, the IMP fermentation. The fermentation conditions of the microorganisms are not particularly limited, and preferably, media and fermentation conditions of the following composition can be used:

lL를 기준으로 포도당 46g, 과당 30g, 효모 추출물 10g, KH2PO4 18g, K2HPO4 42g, 요소 6g, MgSO4ㆍ7H2O 10g, 바이오틴 30㎍, 티아민-HCl 5mg을 포함하고 pH가 6~8인 배지 18L에서 배양 온도 30-32℃로 하여 140시간 정도 배양한다. It contains 46 g of glucose, 30 g of fructose, 10 g of yeast extract, 18 g of KH 2 PO 4, 18 g of K 2 HPO 4, 42 g of urea, 6 g of MgSO 4 7H 2 O, 30 g of biotin, and 5 mg of thiamine-HCl. Incubate for about 140 hours at a culture temperature of 30-32 ° C. in 18 L of 6-8 medium.

본 발명의 일실시예에서는 코리네박테리움 (Corynebacterium) 속 균주를 배양하여 약 5 % 내지 10 %의 IMP가 포함된 발효액을 얻어 사용한다. In one embodiment of the present invention by culturing the strain Corynebacterium ( Coynebacterium ) is used to obtain a fermentation broth containing about 5% to 10% IMP.

5'-이노신산 생산 균주를 배양한 후, 균체를 제거하여 5'-이노신산을 포함하는 발효액을 얻는다. 미생물 발효액으로부터 균체를 제거하는 단계는 여과, 원심분리, 및 열처리로 구성되는 군으로부터 선택되는 방법에 의해 수행될 수 있다. After culturing the 5'-inosinic acid producing strain, the cells are removed to obtain a fermentation broth containing 5'-inosine acid. Removing the cells from the microbial fermentation broth may be performed by a method selected from the group consisting of filtration, centrifugation, and heat treatment.

본 발명의 일실시예에서, 발효액은 막 여과 공정에 의하여 여과된다. 이와 같은 여과 공정에 의하여 발효액은 여과액과 균체 슬러지로 분리된다. 사용되는 막 필터는 발효액으로부터 균체를 분리할 수 있는 것이면 어느 것이나 이용될 수 있다. 막 필터의 운전 조건도 당업자가 발효액으로부터 균체를 분리하기 위하여 용이하게 조건을 설정할 수 있다. 예를 들면, 발효액을 미리 약 40~50 ℃로 가열하고, 발효액의 온도 약 40~50℃, 막 사이의 압력 (TMP) 1.2∼1.5 atm의 조건에서 수행할 수 있다. 사용되는 막의 공극 (pore)의 크기도 또한 당업자가 용이하게 선택할 수 있다.In one embodiment of the invention, the fermentation broth is filtered by a membrane filtration process. By this filtration process, the fermentation broth is separated into filtrate and cell sludge. Any membrane filter to be used may be used as long as it can separate the cells from the fermentation broth. The operating conditions of the membrane filter can also be easily set by those skilled in the art in order to separate the cells from the fermentation broth. For example, the fermentation broth may be heated to about 40-50 ° C. in advance, and the fermentation broth may be performed at a temperature of about 40-50 ° C. and a pressure (TMP) between the membranes of 1.2 to 1.5 atm. The size of the pores of the membrane used can also be readily selected by those skilled in the art.

본 발명의 일실시예에 있어서, 막 여과에 의하여 얻어지는 여과액은 IMP의 함량이 15∼30%가 되도록 건조된다. 이러한 건조 과정은 여과액 중의 수분의 함량을 줄여 여과액의 전체 부피를 감소시키는 동시에, IMP의 함량을 상대적으로 증가시키는 공정이다. 건조 과정은 당업계에 잘 알려져 있다. 건조 과정의 예에는 감압 건조가 포함된다. In one embodiment of the present invention, the filtrate obtained by membrane filtration is dried so that the content of IMP is 15-30%. This drying process reduces the water content in the filtrate to reduce the total volume of the filtrate, while simultaneously increasing the content of IMP. Drying procedures are well known in the art. Examples of drying processes include reduced pressure drying.

농축이 완료되면 균체를 제거한 발효액에 친수성 유기 용매를 첨가하여 결정화 작업을 하기 전에 농축된 발효액의 pH를 조정한다. 결정 석출은 5'-이노신산 이나트륨염이 생성되는 영역, 즉, pH 6~10에서 이루어지므로, 발효액의 pH를 이 범위로 조정한다. 바람직하게는 균체를 제거한 발효액의 pH는 7.5~9.5로 조정한다. When the concentration is completed, the hydrophilic organic solvent is added to the fermentation broth from which the cells are removed to adjust the pH of the concentrated fermentation broth before crystallization. Crystal precipitation occurs in the region where 5'-inosinic acid disodium salt is produced, that is, pH 6-10, so that the pH of the fermentation broth is adjusted to this range. Preferably, the pH of the fermentation broth from which the cells are removed is adjusted to 7.5 to 9.5.

사용하는 친수성 유기 용매로서는 메탄올, 에탄올, 프로판올, 이소프로판올, 또는 이들의 혼합물들을 사용할 수 있다. 바람직하게는, 수득되는 결정의 형상이 고액 분리에 가장 적합한 메탄올을 사용한다. 또한, 사용하는 유기 용매는 물로 희 석하여 사용할 수도 있지만, 희석 배율이 증가하면 용매의 첨가량이 증가하기 때문에 공업적으로는 용매의 농도 범위는 80~100용적%가 바람직하다.As the hydrophilic organic solvent to be used, methanol, ethanol, propanol, isopropanol, or mixtures thereof can be used. Preferably, methanol is used in which the shape of the crystal obtained is most suitable for solid-liquid separation. In addition, although the organic solvent used may be diluted with water and used, since the addition amount of a solvent increases as a dilution magnification increases, industrially, the concentration range of a solvent is preferable from 80 to 100 volume%.

유기용매 주입 첨가 중의 온도는 50~80℃로 설정할 수 있으며, 바람직하게는 65±10℃로 설정한다. 또한, 유기용매 주입 첨가 중에는 냉각 조작 등 온도 변화를 동반할 수 있다.The temperature during organic solvent injection addition can be set to 50 to 80 ° C, preferably 65 ± 10 ° C. In addition, the addition of the organic solvent injection may be accompanied by a temperature change such as a cooling operation.

유기용매 주입 첨가 종료 후, 그대로 즉시 고액 분리를 수행하는 것도 가능하지만, 수율을 향상시키기 위해서 냉각시키는 단계를 더 포함할 수 있다. After completion of the organic solvent injection addition, it is also possible to immediately carry out solid-liquid separation, but may further comprise the step of cooling to improve the yield.

결정 석출계의 액상에서 차지하는 유기 용매의 비율(농도)은 40~80용적%의 범위일 수 있으나, 공업적으로는, 수율 확보를 위해 50용적% 이상이 바람직하다.The proportion (concentration) of the organic solvent in the liquid phase of the crystal precipitation system may be in the range of 40 to 80% by volume, but industrially, 50% by volume or more is preferable to secure a yield.

이를 통해 수득된 결정은 종래의 이노신산 이나트륨의 정제방법과 동일하게 결정 품질에 따라 1회 또는 2회 이상의 활성탄을 이용한 탈색공정 및 결정화 공정을 추가로 거쳐 최종 이노신산 이나트륨 제품을 얻을 수 있으며, 이 때의 결정화 공정은 친수성 유기용매를 이용하거나 농축/냉각 결정법을 이용할 수 있다.Crystals obtained through this process can be obtained in the same way as the conventional method for purifying disodium inosine acid, and further through decolorization and crystallization using activated carbon one or two times to obtain a final disodium inosinate product. The crystallization process at this time may use a hydrophilic organic solvent or a concentrated / cooled crystal method.

활성탄을 이용한 탈색공정은 상기 결정화 과정을 통하여 얻어진 결정을 재용해시킨 용액에 활성탄을 투입하고 일정시간 동안 교반하여 색소성분이 활성탄에 흡착되도록 한 후 활성탄을 분리하는 과정으로 이루어진다.The decolorization process using activated carbon is performed by adding activated carbon to a solution in which the crystals obtained through the crystallization process are re-dissolved and stirring for a predetermined time so that the pigment component is adsorbed onto the activated carbon and then separating the activated carbon.

활성탄을 투입하여 색소성분을 흡착시키는 동안의 온도는 30~80℃로 설정할 수 있지만, 50~70℃에서 수행하는 것이 바람직하다. The temperature during adsorbing the pigment component by adding activated carbon can be set to 30 to 80 ° C., but it is preferably carried out at 50 to 70 ° C.

활성탄을 제거하고 수득한 여과액을 결정화하는 공정은 상기 결정화 과정과 동일하게 친수성 유기용매를 이용하거나 또는 농축 결정법을 이용할 수 있다.The process of removing activated carbon and crystallizing the obtained filtrate may use a hydrophilic organic solvent or a concentrated crystallization method in the same manner as in the above crystallization process.

본 발명의 방법에 따라 얻어지는 IMP2Na 최종 결정은 건조 중량에 대하여, IMP2Na함량이 97.0~102.0%이며, 수분이 28.5% 이하, pH (5% 용액) 7.0~8.5인 특성을 갖는다.The final crystal of IMP2Na obtained according to the method of the present invention has a characteristic of IMP2Na content of 97.0 to 102.0%, moisture of 28.5% or less and pH (5% solution) of 7.0 to 8.5 with respect to dry weight.

이하 본 발명을 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이 실시예들은 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이 실시예들에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, these embodiments are intended to illustrate the present invention by way of example, but the scope of the present invention is not limited to these embodiments.

실시예Example 1 : 친수성 유기용매에 의한 결정화(1차~3차) 방법 적용 1: application of crystallization (primary to tertiary) by hydrophilic organic solvent

본 실시예에서는 IMP가 포함된 발효완료액 6,000ml를 40℃로 가열한 다음, 막 사이의 압력 (TMP) 0.5∼3.0 atm의 조건에서 막 필터(Ceramic Filter Pilot : 공극 크기 0.1 ㎛, 면적 1.0 m2)에 의하여 여과를 수행하여 균체 슬러지와 여과액으로 분리하였다. 상기 여과액을 진공도 680 mmHg, 용기 온도 55 ℃의 조건에서 감압 건조하여 IMP 함량 25 %인 농축액 1,950㎖을 얻고, 농축액 pH를 7.5로 조정한 후 결정 석출관에 투입하였다. 95 용적% 메탄올 수용액 3,120㎖를 6시간 동안 투입하였으며, 메탄올 주입 개시 시 결정 석출관 온도는 70℃이고, 메탄올 주입 첨가가 완료될 때 결정 석출관 온도는 40℃였다. 메탄올 주입 첨가 종료 후 상기 용액을 30℃까지 다시 냉각하고 결정을 분리하였다(1차).In this embodiment, 6,000 ml of the fermentation broth containing IMP is heated to 40 ° C., and then a membrane filter (pore size: 0.1 μm, area of 1.0 m) under conditions of 0.5 to 3.0 atm pressure (TMP) between the membranes. Filtration was carried out by 2 ) to separate the cell sludge and the filtrate. The filtrate was dried under reduced pressure at a vacuum degree of 680 mmHg and a container temperature of 55 ° C. to obtain 1,950 ml of a concentrate having an IMP content of 25%. 3,120 mL of an aqueous solution of 95% by volume methanol was added for 6 hours. The crystal precipitation tube temperature was 70 ° C. at the start of methanol injection and 40 ° C. when the methanol injection addition was completed. After completion of the methanol injection addition the solution was cooled again to 30 ° C. and crystals were separated (primary).

분리된 결정을 IMP 농도 30%로 탈이온수(DIW: deionized water)에 재용해시킨 후 활성탄을 첨가하여 교반 상태로 1시간 동안 온도 60℃에서 유지시킨 후 활성탄을 분리하였다. The separated crystals were redissolved in deionized water (DIW) at an IMP concentration of 30%, and activated carbon was added thereto and maintained at a temperature of 60 ° C. for 1 hour while stirring to separate activated carbon.

활성탄이 제거된 여과액 2,190㎖를 결정 석출관에 투입한 후 55℃로 보온하고, 95용적% 메탄올 수용액 1,752㎖를 3시간 동안 투입하였다. 메탄올 주입 첨가 종료 후 결과물인 용액을 25℃까지 냉각하고 결정을 분리하였다(2차).2,190 ml of the filtrate from which activated carbon was removed was added to a crystal precipitation tube, and warmed to 55 ° C., and 1,752 ml of 95% by volume aqueous methanol solution was added for 3 hours. After completion of the methanol injection addition, the resulting solution was cooled to 25 ° C. and crystals were separated (secondary).

분리된 결정을 IMP 농도 30%로 탈이온수에 재용해시킨 후 활성탄을 첨가하여 교반 상태로 1시간 동안 온도 60℃에서 유지시킨 후 활성탄을 분리하였다.The separated crystals were redissolved in deionized water at an IMP concentration of 30%, activated carbon was added thereto, maintained at a temperature of 60 ° C. under stirring for 1 hour, and then activated carbon was separated.

활성탄이 제거된 여과액 866㎖를 결정 석출관에 투입한 후 60℃로 보온하고, 95용적% 메탄올 수용액 866㎖를 3시간 동안 투입하였다. 메탄올 주입 첨가 종료 후 30℃까지 냉각하고 결정을 분리한 후 건조시켰다(3차).866 ml of the filtrate from which activated carbon was removed was added to a crystal precipitation tube, and then heated to 60 ° C., and 866 ml of 95% by volume aqueous methanol solution was added for 3 hours. After completion of the methanol injection addition, the mixture was cooled to 30 ° C, crystals were separated, and dried (tertiary).

본 실시예에서 얻어지는 최종 IMP2Na 결정은 IMP 함량 99.5%, 수분 22.7%, pH 7.6 (5% 수용액) 이었으며, 총 중량은 369.5g이었다.The final IMP2Na crystals obtained in this example had an IMP content of 99.5%, moisture 22.7%, pH 7.6 (5% aqueous solution), and a total weight of 369.5 g.

실시예Example 2 : 친수성 유기용매에 의한 결정화 (1~2차) + 농축/결정화(3차) 방법 적용 2: crystallization by hydrophilic organic solvent (1st ~ 2nd) + concentration / crystallization (3rd) method applied

본 실시예에서는 IMP가 포함된 발효완료액 3,900ml를 50℃로 가열한 다음, 막 사이의 압력 (TMP) 0.5∼3.0 atm의 조건에서 막 필터 (Ceramic Filter Pilot : 공극 크기 0.1 ㎛, 면적 1.0 m2)에 의하여 여과를 수행하여 균체 슬러지와 여과액으로 분리하였다. 상기 여과액을 진공도 680 mmHg, 용기 온도 55 ℃의 조건에서 감압 건조하여 IMP 함량 20 %인 농축액 2,430㎖을 얻고, 농축액 pH를 8.0으로 조정한 후 결정 석출관에 투입하였다. 메탄올 주입 개시 시 결정 석출관 온도는 65℃이고, 메탄올 주입 첨가가 완료될 때 결정 석출관 온도는 30℃였다. 메탄올 주입 첨가 종료 후 상기 용액을 20℃까지 냉각시키고 결정을 분리하였다(1차).In this embodiment, 3,900 ml of the fermentation broth containing IMP is heated to 50 ° C., and then a membrane filter (pore size 0.1 μm, area 1.0 m) under conditions of 0.5 to 3.0 atm pressure (TMP) between the membranes. Filtration was carried out by 2 ) to separate the cell sludge and the filtrate. The filtrate was dried under reduced pressure at a vacuum degree of 680 mmHg and a vessel temperature of 55 ° C. to obtain 2,430 ml of a concentrate having an IMP content of 20%. The concentrate was adjusted to 8.0, and then charged into a crystal precipitation tube. The crystal precipitation tube temperature was 65 ° C. at the start of methanol injection, and the crystal precipitation tube temperature was 30 ° C. when the methanol injection addition was completed. After completion of the methanol injection addition the solution was cooled to 20 ° C. and crystals were separated (primary).

분리된 결정을 IMP 농도 30%로 탈이온수에 재용해시킨 후, 활성탄을 첨가하여 교반 상태로 1시간 동안 온도 60℃에서 유지시킨 후 활성탄을 분리하였다. The separated crystals were redissolved in deionized water at an IMP concentration of 30%, and then activated carbon was added thereto and maintained at a temperature of 60 ° C. for 1 hour under stirring to separate activated carbon.

활성탄이 제거된 여과액 2,190㎖를 결정 석출관에 투입한 후 45℃로 보온하고, 95용적% 메탄올 수용액 1,970㎖를 3시간 동안 투입하였다. 메탄올 주입 첨가 종료 후 결과물인 용액을 30℃까지 냉각하고 결정을 분리하였다(2차).2190 mL of the filtrate from which activated carbon was removed was added to a crystal precipitation tube, and then heated to 45 ° C., and 1,970 mL of a 95% by volume aqueous methanol solution was added for 3 hours. After completion of the methanol injection addition, the resulting solution was cooled to 30 ° C. and crystals were separated (secondary).

분리된 결정은 IMP 농도 30%로 탈이온수에 재용해시킨 후 활성탄을 첨가하고 교반 상태로 1시간 동안 온도 60℃에서 유지시킨 후 활성탄을 분리하였다.The separated crystals were redissolved in deionized water at an IMP concentration of 30%, activated carbon was added, and the activated carbon was separated after being maintained at a temperature of 60 ° C. for 1 hour while stirring.

활성탄이 제거된 여과액 866㎖를 진공도 680 mmHg, 용기 온도 55 ℃의 조건에서 감압 건조하여 IMP 농도 68%로 농축한 다음 결정 석출관에 투입한 후 5시간 동안 15℃까지 냉각하고 결정을 분리한 후 건조하였다(3차). 866 ml of the filtrate from which activated charcoal was removed was dried under reduced pressure at a vacuum degree of 680 mmHg and a container temperature of 55 ° C., concentrated to 68% IMP concentration, added to a crystal precipitation tube, cooled to 15 ° C. for 5 hours, and crystals were separated. It was then dried (tertiary).

본 실시예에서 얻어지는 최종 IMP2Na 결정은 IMP 함량 101.0%, 수분 20.4 %, pH 7.9 (5% 수용액) 이었으며, 총 중량은 255.8g이었다. The final IMP2Na crystals obtained in this example were IMP content 101.0%, moisture 20.4%, pH 7.9 (5% aqueous solution), and the total weight was 255.8 g.

실시예Example 3 : 친수성 유기용매에 의한 결정화 (1차) + 농축/결정화(2~3차) 방법 적용 3: Crystallization by hydrophilic organic solvent (primary) + concentration / crystallization (second to third) method applied

본 실시예에서는 IMP가 포함된 발효완료액 4,600ml를 50℃로 가열한 다음, 막 사이의 압력 (TMP) 0.5∼3.0 atm의 조건에서 막 필터(Ceramic Filter Pilot : 공극 크기 0.1 ㎛, 면적 1.0 m2)에 의하여 여과를 수행하여 균체 슬러지와 여과액으로 분리하였다. 상기 여과액을 진공도 680 mmHg, 용기 온도 55 ℃의 조건에서 감압 건조하여 IMP 함량 30 %인 농축액 1,010㎖을 얻고, 농축액 pH를 8.5로 조정한 후 결정 석출관에 투입하였다. 95용적% 메탄올 수용액 1,515㎖를 4시간 동안 투입하였으며, 메탄올 주입 개시 시 결정 석출관 온도는 75℃이고, 메탄올 주입 첨가가 완료될 때 결정 석출관 온도는 35℃였다. 메탄올 주입 첨가 종료 후 상기 용액을 25℃까지 냉각하고 결정을 분리하였다(1차).In this embodiment, 4,600 ml of the fermentation broth containing IMP is heated to 50 ° C., and then a membrane filter (pore size: 0.1 μm, area of 1.0 m) under conditions of 0.5 to 3.0 atm pressure (TMP) between the membranes. Filtration was carried out by 2 ) to separate the cell sludge and the filtrate. The filtrate was dried under reduced pressure at a vacuum degree of 680 mmHg and a container temperature of 55 ° C. to obtain 1,010 ml of a concentrate having an IMP content of 30%. The pH of the concentrate was adjusted to 8.5, and then poured into a crystal precipitation tube. 1,515 ml of 95% by volume aqueous methanol solution was added for 4 hours. The crystal precipitation tube temperature was 75 ° C. at the start of methanol injection, and the crystal precipitation tube temperature was 35 ° C. when the methanol injection addition was completed. After completion of the methanol injection addition the solution was cooled to 25 ° C. and crystals were separated (primary).

분리된 결정은 IMP 농도 30%로 탈이온수에 재용해시킨 후 활성탄을 첨가하고 교반 상태로 1시간 동안 온도 60℃에서 유지시킨 후 활성탄을 분리하였다. The separated crystals were redissolved in deionized water at an IMP concentration of 30%, activated carbon was added, and the activated carbon was separated after being maintained at a temperature of 60 ° C. for 1 hour while stirring.

활성탄이 제거된 여과액 1,270㎖를 진공도 680 mmHg, 용기 온도 55 ℃의 조건에서 감압 건조하여 IMP 농도 68%로 농축한 다음 결정 석출관에 투입한 후 4시간 동안 15℃까지 냉각하고 결정을 분리하였다(2차).1,270 ml of the filtrate from which activated carbon was removed were dried under reduced pressure at a vacuum degree of 680 mmHg and a container temperature of 55 ° C., concentrated to 68% of IMP concentration, and then charged into a crystal precipitation tube. (Secondary).

분리된 결정은 IMP 농도 30%로 탈이온수에 재용해시킨 후 활성탄을 첨가하고 교반한 상태로 1시간 동안 온도 60℃에서 유지시킨 후 활성탄을 분리하였다.The separated crystals were re-dissolved in deionized water at an IMP concentration of 30%, activated carbon was added and maintained at a temperature of 60 ° C. for 1 hour, followed by separation of activated carbon.

활성탄이 제거된 여과액 633㎖를 진공도 680 mmHg, 용기 온도 55 ℃의 조건에서 감압 건조하여 IMP 농도 68%로 농축한 다음 결정 석출관에 투입한 후 5시간 동안 12℃까지 냉각하고 결정을 분리한 후 건조하였다(3차). 633 ml of the filtrate from which activated carbon was removed were dried under reduced pressure at a vacuum degree of 680 mmHg and a container temperature of 55 ° C., concentrated to 68% of IMP concentration, and then charged into a crystal precipitation tube. It was then dried (tertiary).

본 실시예에서 얻어지는 최종 IMP2Na 결정은 IMP 함량 99.9%, 수분 16.8%, pH 7.8 (5% 수용액) 이었으며, 총 중량은 179.7g이었다. The final IMP 2 Na crystals obtained in this example were 99.9% IMP content, 16.8% moisture, pH 7.8 (5% aqueous solution), and the total weight was 179.7 g.

본 발명에 따른 미생물 발효액으로부터의 IMP의 정제방법에 의하면, 이온교환수지탑 공정 없이 결정화 공정만으로 식품첨가물로서 사용 가능한 IMP2Na 제품 생산이 가능하며, 이온교환수지탑 공정이 없으므로 정제공정에서 발생되는 폐액/폐수 발생량 및 용리제/재생제로 사용되는 산,알카리 같은 화학약품 사용량을 대폭 감소시킬 수 있다.According to the method for purifying IMP from the microbial fermentation broth according to the present invention, it is possible to produce IMP2Na products which can be used as food additives only by the crystallization process without the ion exchange resin tower process, and there is no ion exchange resin tower process. The amount of wastewater generated and the use of chemicals such as acids and alkalis used as eluents / regenerators can be greatly reduced.

Claims (11)

5'-이노신산 생산 균주를 배양하고, 균체를 제거하여 5'-이노신산을 포함하는 발효액을 얻는 단계; Culturing the 5'-inosinic acid producing strain, and removing the cells to obtain a fermentation broth containing 5'-inosinic acid; 상기 발효액에 친수성 유기용매를 첨가하여 5'-이노신산 이나트륨을 결정화하는 단계;Crystallizing disodium 5'-inosinate by adding a hydrophilic organic solvent to the fermentation broth; 상기 결정을 재용해하고 활성탄을 이용하여 탈색시키는 단계; 및Redissolution of the crystals and decolorizing with activated carbon; And 상기 활성탄을 제거하고 수득한 여과액을 결정화하는 단계;를 포함하는 균주 발효액으로부터 5'-이노신산 이나트륨을 정제하는 방법.Removing the activated carbon and crystallizing the obtained filtrate; a method for purifying disodium 5'-inosinate from a strain fermentation broth comprising. 제1항에 있어서, 상기 균체를 제거하는 단계는 여과, 원심분리, 및 열처리로 구성되는 군으로부터 선택되는 방법에 의해 수행되는 것을 특징으로 하는 방법. The method of claim 1, wherein the removing the cells is performed by a method selected from the group consisting of filtration, centrifugation, and heat treatment. 제1항에 있어서, 상기 균체가 제거된 발효액의 pH는 6~10으로 조정되는 것을 특징으로 하는 방법.The method according to claim 1, wherein the pH of the fermentation broth from which the cells are removed is adjusted to 6-10. 제3항에 있어서, 상기 균체가 제거된 발효액의 pH는 7.5~9.5로 조정되는 것을 특징으로 하는 방법.The method according to claim 3, wherein the pH of the fermentation broth from which the cells are removed is adjusted to 7.5 to 9.5. 제1항에 있어서, 상기 친수성 유기용매는 메탄올, 에탄올, 프로판올, 이소프 로판올 및 이들의 혼합물들로 구성되는 군으로부터 선택되는 하나 이상의 용매인 것을 특징으로 하는 방법.The method of claim 1, wherein the hydrophilic organic solvent is at least one solvent selected from the group consisting of methanol, ethanol, propanol, isopropanol and mixtures thereof. 제1항에 있어서, 상기 친수성 유기용매는 메탄올인 것을 특징으로 하는 방법.The method of claim 1, wherein the hydrophilic organic solvent is methanol. 제1항에 있어서, 상기 친수성 유기용매의 첨가는 50~80℃에서 수행되는 것을 특징으로 하는 방법.The method of claim 1, wherein the addition of the hydrophilic organic solvent is carried out at 50 ~ 80 ℃. 제1항에 있어서, 상기 유기용매를 첨가한 후, 냉각시키는 단계를 더 포함하는 것을 특징으로 하는 방법.The method of claim 1, further comprising the step of cooling after adding the organic solvent. 제1항에 있어서, 상기 활성탄을 이용한 탈색 단계는 30~80℃에서 수행되는 것을 특징으로 하는 방법.The method of claim 1, wherein the decolorizing step using the activated carbon is carried out at 30 ~ 80 ℃. 제1항에 있어서, 상기 활성탄을 이용하여 탈색하는 단계는 2회 이상 수행되는 것을 특징으로 하는 방법.The method of claim 1, wherein the decolorizing using the activated carbon is performed two or more times. 제1항에 있어서, 상기 활성탄을 제거하고 수득한 여과액을 결정화하는 단계는 유기용매를 이용하거나 농축을 이용하여 수행되는 것을 특징으로 하는 방법.The method according to claim 1, wherein the step of removing the activated carbon and crystallizing the filtrate obtained is carried out using an organic solvent or using concentration.
KR1020060067305A 2006-07-19 2006-07-19 A method for purifying 5'-Inosinic acid fermentation broth via crystallization process KR100828706B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020060067305A KR100828706B1 (en) 2006-07-19 2006-07-19 A method for purifying 5'-Inosinic acid fermentation broth via crystallization process
CNA2007101294873A CN101109017A (en) 2006-07-19 2007-07-19 Method for purifying 5-inosinic acid zymotic fluid by crystallization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060067305A KR100828706B1 (en) 2006-07-19 2006-07-19 A method for purifying 5'-Inosinic acid fermentation broth via crystallization process

Publications (2)

Publication Number Publication Date
KR20080007985A true KR20080007985A (en) 2008-01-23
KR100828706B1 KR100828706B1 (en) 2008-05-09

Family

ID=39041275

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060067305A KR100828706B1 (en) 2006-07-19 2006-07-19 A method for purifying 5'-Inosinic acid fermentation broth via crystallization process

Country Status (2)

Country Link
KR (1) KR100828706B1 (en)
CN (1) CN101109017A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021075734A1 (en) * 2019-10-17 2021-04-22 씨제이제일제당(주) Method for separating disodium 5'-inosinate
WO2021101042A1 (en) * 2019-11-20 2021-05-27 씨제이제일제당 (주) Method for refining nucleic acids

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102199182A (en) * 2011-04-10 2011-09-28 浙江钱江生物化学股份有限公司 One-step extraction method for disodium 5'-inosinate
KR101896240B1 (en) 2018-06-20 2018-10-18 주식회사 아리바이오 Decolorization method of Aureobasidium pullulans fermentation broth
CN111286521A (en) * 2020-03-02 2020-06-16 通辽梅花生物科技有限公司 Preparation method of flavour development nucleotide disodium
CN111748592B (en) * 2020-07-17 2022-03-15 通辽梅花生物科技有限公司 Preparation method of high-purity flavor nucleotide disodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6601640A (en) 1965-02-11 1966-08-12
NL6608027A (en) 1965-06-10 1966-12-12
JPH0669386B2 (en) 1987-03-18 1994-09-07 協和醗酵工業株式会社 Process for producing 5'-inosinic acid

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021075734A1 (en) * 2019-10-17 2021-04-22 씨제이제일제당(주) Method for separating disodium 5'-inosinate
KR20210045833A (en) * 2019-10-17 2021-04-27 씨제이제일제당 (주) Method of separating disodium 5'-inosinic acid from a cell culture
JP2022550340A (en) * 2019-10-17 2022-12-01 シージェイ チェイルジェダン コーポレーション Method for separating disodium 5'-inosinate
AU2020368796B2 (en) * 2019-10-17 2023-07-13 Cj Cheiljedang Corporation Method for separating disodium 5'-inosinate
WO2021101042A1 (en) * 2019-11-20 2021-05-27 씨제이제일제당 (주) Method for refining nucleic acids

Also Published As

Publication number Publication date
CN101109017A (en) 2008-01-23
KR100828706B1 (en) 2008-05-09

Similar Documents

Publication Publication Date Title
DK202000086U1 (en) Separation of 2'-fl from a fermentation broth
CA1336584C (en) Process and apparatus for manufacturing ethanol, glycerol, succinic acid and distiller's dry grain and solubles
CN102976923B (en) New process for extracting lactic acid from lactic acid fermentation liquid
EP3233875A1 (en) Separation of 2'-fl from a fermentation broth
KR100828706B1 (en) A method for purifying 5'-Inosinic acid fermentation broth via crystallization process
AU2011214268A1 (en) Process for manufacturing succinic acid
CN105017360B (en) A kind of preparation method of vitamin B12
CN101633634A (en) Method for extracting L-proline from fermentation liquor by membrane separation technology
CN110776543A (en) Method for recovering adenosine primary mother liquor
CN107383135B (en) Method for separating and purifying beta-thymidine from fermentation liquor
CN105837488B (en) A kind of hydroxyproline fermentation manufacturing technique
US20070037266A1 (en) Process for producing erythritol
CN101302549A (en) High-purity miglitol production process
JP2024507514A (en) Xylitol fermentation liquid purification system and method
CN110372606B (en) Method for separating and purifying cytosine from microbial fermentation liquor
CN106883286B (en) Extraction and purification method of tyrosine derivative
CN111065644B (en) Method for preparing high-purity NAD
CN116496222B (en) Method for separating and purifying tetrahydropyrimidine from fermentation liquor
JP6692232B2 (en) 3HB manufacturing method
JP3819542B2 (en) Purification method of erythritol
JPH08506248A (en) Method for producing α, α-trehalase
CN116496336A (en) Method for extracting thymidine from fermentation broth
CN113968794A (en) Process method for separating and purifying glutamine
CN116874537A (en) Preparation method of high-purity nicotinamide adenine dinucleotide
JP3965223B2 (en) Purification method of erythritol

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130315

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20140228

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20150227

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20180226

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20190225

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20200225

Year of fee payment: 13